Jay Venkatesan is Director of ALPINE IMMUNE SCIENCES, INC.. Currently has a direct ownership of 238,126 shares of ALPN, which is worth approximately $0. The most recent transaction as insider was on Jul 15, 2022, when has been sold 20,063 shares (Common Stock) at a price of $0.45 per share, resulting in proceeds of $9,028. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 238K
0% 3M change
0% 12M change
Total Value Held $0

Jay Venkatesan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 15 2022
BUY
Exercise of conversion of derivative security
$9,028 $0.45 p/Share
20,063 Added 7.77%
238,126 Common Stock
Mar 31 2021
BUY
Exercise of conversion of derivative security
$27,693 $3.62 p/Share
7,650 Added 3.39%
218,063 Common Stock
Mar 30 2021
BUY
Exercise of conversion of derivative security
$31,289 $4.09 p/Share
7,650 Added 3.51%
210,413 Common Stock
Dec 22 2020
BUY
Other acquisition or disposition
-
181,024 Added 47.17%
202,763 Common Stock

Also insider at

ANGN
Angion Biomedica Corp. Healthcare
JV

Jay Venkatesan

Director
Seattle, WA

Track Institutional and Insider Activities on ALPN

Follow ALPINE IMMUNE SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALPN shares.

Notify only if

Insider Trading

Get notified when an Alpine Immune Sciences, Inc. insider buys or sells ALPN shares.

Notify only if

News

Receive news related to ALPINE IMMUNE SCIENCES, INC.

Track Activities on ALPN